US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist

0.544
+0.029+5.61%

Close May 1 16:00 ET

0.540
-0.004-0.70%

Pre 08:00 ET

112.84MMarket Cap-367P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-0.54%-224.84M

11.41%-50.54M

11.80%-47.29M

-12.46%-60.71M

-12.42%-66.3M

4.13%-223.63M

-8.22%-57.05M

9.76%-53.62M

-2.70%-53.99M

13.97%-58.98M

Net income from continuing operations

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.84%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.48%-43.17M

4.27%-43.98M

Depreciation and amortization

7.93%22.19M

-44.69%3.01M

43.22%7.42M

23.57%6.18M

13.02%5.58M

16.58%20.56M

11.96%5.44M

12.83%5.18M

16.65%5M

26.68%4.94M

Deferred tax

---6.34M

---140K

--182K

----

--0

----

Other non cash items

--1.12M

--0

----

Change In working capital

-99.27%-164.03M

104.39%783K

79.29%-2.67M

85.99%-3.33M

-471.46%-158.81M

19.21%-82.32M

19.45%-17.85M

48.02%-12.91M

-18.71%-23.78M

20.33%-27.79M

-Change in receivables

66.51%3.15M

-25.96%425K

75.50%2.19M

310.17%4.11M

-283.80%-3.58M

1,934.95%1.89M

-74.20%574K

238.64%1.25M

990.22%1M

38.76%-932K

-Change in prepaid assets

224.93%6.13M

3.73%974K

54.56%-389K

85.79%-675K

2,682.16%6.22M

31.58%-4.91M

232.63%939K

57.75%-856K

-72.08%-4.75M

85.65%-241K

-Change in payables and accrued expense

-58.13%5.59M

176.80%10.81M

-38.32%6.33M

-117.69%-9.65M

-152.78%-1.91M

274.16%13.35M

231.70%3.91M

786.62%10.27M

-808.96%-4.43M

194.25%3.61M

-Change in other current liabilities

-123.96%-5.06M

-251.53%-1.43M

-6.95%-1.23M

-9.55%-1.2M

-24.87%-1.19M

27.72%-2.26M

185.83%945K

-25.24%-1.15M

-27.94%-1.1M

-288.98%-953K

-Change in other working capital

-92.33%-173.85M

58.72%-9.99M

57.30%-9.57M

128.15%4.08M

-440.97%-158.37M

-7.83%-90.39M

-23.48%-24.21M

-14.98%-22.41M

15.35%-14.5M

-6.03%-29.27M

Cash from discontinued investing activities

Operating cash flow

-0.54%-224.84M

11.41%-50.54M

11.80%-47.29M

-12.46%-60.71M

-12.42%-66.3M

4.13%-223.63M

-8.22%-57.05M

9.76%-53.62M

-2.70%-53.99M

13.97%-58.98M

Investing cash flow

Cash flow from continuing investing activities

158.97%153.53M

-11.51%37.71M

379.51%37.63M

49.38%42.47M

1,995.48%35.73M

-76.11%59.29M

-19.04%42.61M

-122.08%-13.46M

-68.16%28.43M

-96.24%1.71M

Net PPE purchase and sale

-4.88%-21.16M

64.26%-2.67M

37.82%-2.74M

-1.74%-5.54M

-259.28%-10.2M

13.35%-20.17M

-161.51%-7.47M

15.25%-4.41M

25.03%-5.45M

64.29%-2.84M

Net business purchase and sale

--0

----

--0

----

Net investment purchase and sale

119.85%174.69M

-19.38%40.38M

546.14%40.37M

41.73%48.01M

910.74%45.93M

-70.74%79.46M

-9.74%50.09M

-113.67%-9.05M

-64.94%33.87M

-91.48%4.54M

Cash from discontinued investing activities

Investing cash flow

158.97%153.53M

-11.51%37.71M

379.51%37.63M

49.38%42.47M

1,995.48%35.73M

-76.11%59.29M

-19.04%42.61M

-122.08%-13.46M

-68.16%28.43M

-96.24%1.71M

Financing cash flow

Cash flow from continuing financing activities

-82.77%14.59M

-99.15%167K

-100.23%-100K

-71.50%6.52M

610.66%8M

157.65%84.66M

824.95%19.54M

697.85%43.82M

128.31%22.87M

-110.29%-1.57M

Net common stock issuance

-82.20%15.11M

-104.02%-719K

-98.40%720K

-72.67%5.99M

--9.11M

213.18%84.87M

--17.91M

823.58%45.03M

233.67%21.93M

--0

Proceeds from stock option exercised by employees

-50.66%935K

-47.20%935K

33.49%-719K

-36.43%719K

--0

-78.98%1.9M

-25.65%1.77M

-222.98%-1.08M

-71.28%1.13M

-95.93%74K

Net other financing activities

30.94%-1.45M

65.49%-49K

25.19%-101K

-4.30%-194K

32.42%-1.11M

35.42%-2.1M

47.41%-142K

48.67%-135K

62.12%-186K

26.54%-1.64M

Cash from discontinued financing activities

Financing cash flow

-82.77%14.59M

-99.15%167K

-100.23%-100K

-71.50%6.52M

610.66%8M

157.65%84.66M

824.95%19.54M

697.85%43.82M

128.31%22.87M

-110.29%-1.57M

Net cash flow

Beginning cash position

-43.48%101.94M

-39.61%58.01M

-42.68%68.33M

-34.51%79.74M

-43.48%101.94M

35.79%180.37M

-46.17%96.07M

-30.44%119.21M

-2.18%121.76M

35.79%180.37M

Current changes in cash

28.81%-56.72M

-348.34%-12.66M

58.02%-9.77M

-337.14%-11.72M

61.64%-22.57M

-266.68%-79.68M

150.81%5.1M

-430.05%-23.26M

-105.74%-2.68M

-633.08%-58.84M

Effect of exchange rate changes

18.26%1.48M

74.58%1.35M

-533.07%-550K

140.77%313K

65.32%367K

576.81%1.25M

773.91%775K

353.57%127K

-14.47%130K

167.68%222K

End cash Position

-54.19%46.7M

-39.61%58.01M

-42.68%68.33M

-34.51%79.74M

-43.48%101.94M

-46.17%96.07M

-30.44%119.21M

-2.18%121.76M

Free cash flow

-0.90%-246M

17.53%-53.21M

13.78%-50.04M

-11.48%-66.25M

-23.76%-76.5M

4.96%-243.8M

-16.11%-64.52M

10.21%-58.03M

0.67%-59.43M

19.20%-61.81M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-0.54%-224.84M	11.41%-50.54M	11.80%-47.29M	-12.46%-60.71M	-12.42%-66.3M	4.13%-223.63M	-8.22%-57.05M	9.76%-53.62M	-2.70%-53.99M	13.97%-58.98M
Net income from continuing operations	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.84%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.48%-43.17M	4.27%-43.98M
Depreciation and amortization	7.93%22.19M	-44.69%3.01M	43.22%7.42M	23.57%6.18M	13.02%5.58M	16.58%20.56M	11.96%5.44M	12.83%5.18M	16.65%5M	26.68%4.94M
Deferred tax	---6.34M	---140K	--182K	----	----	--0	--0	--0	----	----
Other non cash items	--1.12M	--0	----	----	----	----	----	----	----	----
Change In working capital	-99.27%-164.03M	104.39%783K	79.29%-2.67M	85.99%-3.33M	-471.46%-158.81M	19.21%-82.32M	19.45%-17.85M	48.02%-12.91M	-18.71%-23.78M	20.33%-27.79M
-Change in receivables	66.51%3.15M	-25.96%425K	75.50%2.19M	310.17%4.11M	-283.80%-3.58M	1,934.95%1.89M	-74.20%574K	238.64%1.25M	990.22%1M	38.76%-932K
-Change in prepaid assets	224.93%6.13M	3.73%974K	54.56%-389K	85.79%-675K	2,682.16%6.22M	31.58%-4.91M	232.63%939K	57.75%-856K	-72.08%-4.75M	85.65%-241K
-Change in payables and accrued expense	-58.13%5.59M	176.80%10.81M	-38.32%6.33M	-117.69%-9.65M	-152.78%-1.91M	274.16%13.35M	231.70%3.91M	786.62%10.27M	-808.96%-4.43M	194.25%3.61M
-Change in other current liabilities	-123.96%-5.06M	-251.53%-1.43M	-6.95%-1.23M	-9.55%-1.2M	-24.87%-1.19M	27.72%-2.26M	185.83%945K	-25.24%-1.15M	-27.94%-1.1M	-288.98%-953K
-Change in other working capital	-92.33%-173.85M	58.72%-9.99M	57.30%-9.57M	128.15%4.08M	-440.97%-158.37M	-7.83%-90.39M	-23.48%-24.21M	-14.98%-22.41M	15.35%-14.5M	-6.03%-29.27M
Cash from discontinued investing activities
Operating cash flow	-0.54%-224.84M	11.41%-50.54M	11.80%-47.29M	-12.46%-60.71M	-12.42%-66.3M	4.13%-223.63M	-8.22%-57.05M	9.76%-53.62M	-2.70%-53.99M	13.97%-58.98M
Investing cash flow
Cash flow from continuing investing activities	158.97%153.53M	-11.51%37.71M	379.51%37.63M	49.38%42.47M	1,995.48%35.73M	-76.11%59.29M	-19.04%42.61M	-122.08%-13.46M	-68.16%28.43M	-96.24%1.71M
Net PPE purchase and sale	-4.88%-21.16M	64.26%-2.67M	37.82%-2.74M	-1.74%-5.54M	-259.28%-10.2M	13.35%-20.17M	-161.51%-7.47M	15.25%-4.41M	25.03%-5.45M	64.29%-2.84M
Net business purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	119.85%174.69M	-19.38%40.38M	546.14%40.37M	41.73%48.01M	910.74%45.93M	-70.74%79.46M	-9.74%50.09M	-113.67%-9.05M	-64.94%33.87M	-91.48%4.54M
Cash from discontinued investing activities
Investing cash flow	158.97%153.53M	-11.51%37.71M	379.51%37.63M	49.38%42.47M	1,995.48%35.73M	-76.11%59.29M	-19.04%42.61M	-122.08%-13.46M	-68.16%28.43M	-96.24%1.71M
Financing cash flow
Cash flow from continuing financing activities	-82.77%14.59M	-99.15%167K	-100.23%-100K	-71.50%6.52M	610.66%8M	157.65%84.66M	824.95%19.54M	697.85%43.82M	128.31%22.87M	-110.29%-1.57M
Net common stock issuance	-82.20%15.11M	-104.02%-719K	-98.40%720K	-72.67%5.99M	--9.11M	213.18%84.87M	--17.91M	823.58%45.03M	233.67%21.93M	--0
Proceeds from stock option exercised by employees	-50.66%935K	-47.20%935K	33.49%-719K	-36.43%719K	--0	-78.98%1.9M	-25.65%1.77M	-222.98%-1.08M	-71.28%1.13M	-95.93%74K
Net other financing activities	30.94%-1.45M	65.49%-49K	25.19%-101K	-4.30%-194K	32.42%-1.11M	35.42%-2.1M	47.41%-142K	48.67%-135K	62.12%-186K	26.54%-1.64M
Cash from discontinued financing activities
Financing cash flow	-82.77%14.59M	-99.15%167K	-100.23%-100K	-71.50%6.52M	610.66%8M	157.65%84.66M	824.95%19.54M	697.85%43.82M	128.31%22.87M	-110.29%-1.57M
Net cash flow
Beginning cash position	-43.48%101.94M	-39.61%58.01M	-42.68%68.33M	-34.51%79.74M	-43.48%101.94M	35.79%180.37M	-46.17%96.07M	-30.44%119.21M	-2.18%121.76M	35.79%180.37M
Current changes in cash	28.81%-56.72M	-348.34%-12.66M	58.02%-9.77M	-337.14%-11.72M	61.64%-22.57M	-266.68%-79.68M	150.81%5.1M	-430.05%-23.26M	-105.74%-2.68M	-633.08%-58.84M
Effect of exchange rate changes	18.26%1.48M	74.58%1.35M	-533.07%-550K	140.77%313K	65.32%367K	576.81%1.25M	773.91%775K	353.57%127K	-14.47%130K	167.68%222K
End cash Position	-54.19%46.7M	-54.19%46.7M	-39.61%58.01M	-42.68%68.33M	-34.51%79.74M	-43.48%101.94M	-43.48%101.94M	-46.17%96.07M	-30.44%119.21M	-2.18%121.76M
Free cash flow	-0.90%-246M	17.53%-53.21M	13.78%-50.04M	-11.48%-66.25M	-23.76%-76.5M	4.96%-243.8M	-16.11%-64.52M	10.21%-58.03M	0.67%-59.43M	19.20%-61.81M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall